{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:58:02Z","timestamp":1794009482409,"version":"4.8.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702057"],"award-info":[{"award-number":["81702057"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Many efforts have been focused on the alternative glycemic marker glycated albumin (GlyA) and its application in pregnancy during which profound physiological changes take place. Our objective was to determine the reference intervals (RIs) of GlyA in healthy Chinese pregnant women and to assess the predictive value of serum GlyA in adverse pregnancy outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Totally 421 healthy subjects including 137 in the first trimester, 152 in the second trimester, and 132 in the third trimester were enrolled from March to July 2019, for the purpose of establishing the trimester-specific RIs of GlyA. In addition, 67 pregnant women diagnosed with GDM were enrolled at 24\u201328\u2009weeks of gestation. The diagnostic value of GlyA for GDM patients was evaluated and compared with that of fasting plasma glucose (FPG) at 24\u201328\u2009weeks of gestation. The association between GlyA in the late pregnancy and the adverse pregnancy outcomes was analyzed with the data collected from January to June 2018 at our hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The estimated RIs of GlyA in present study were 11.26\u201315.10%, 10.04\u201313.50%, and 9.76\u201313.09% in the first, second, and third trimesters respectively. The areas under receiver operating characteristic (ROC) curves were 0.503 for GlyA and 0.705 for FPG. More importantly, the GlyA level in the third trimester was not more elevated in the patients with adverse pregnancy outcomes including large for gestational age (LGA), preterm delivery, hypertension and preeclampsia (PE). The exception was made with the GDM patients who suffered from postpartum hemorrhage and had significantly higher GlyA levels than the control group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results showed that the GlyA was continuously decreased as the gestational age went up. The GlyA testing has limited value in diagnosing GDM and predicting adverse pregnancy outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-019-2704-x","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T11:03:11Z","timestamp":1578049391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Glycated albumin in pregnancy: reference intervals establishment and its predictive value in adverse pregnancy outcomes"],"prefix":"10.1186","volume":"20","author":[{"given":"Ying","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingrui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lican","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0968-1864","authenticated-orcid":false,"given":"Zheng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,3]]},"reference":[{"key":"2704_CR1","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.2337\/dc17-S003","volume":"40","author":"American Diabetes A","year":"2017","unstructured":"American Diabetes A. Standards of medical Care in Diabetes-2017: summary of revisions. Diabetes Care. 2017;40:S4\u20135 https:\/\/doi.org\/10.2337\/dc17-S003.","journal-title":"Diabetes Care"},{"key":"2704_CR2","doi-asserted-by":"publisher","first-page":"2746471","DOI":"10.1155\/2017\/2746471","volume":"2017","author":"C Caissutti","year":"2017","unstructured":"Caissutti C, Berghella V. Scientific evidence for different options for GDM screening and management: controversies and review of the literature. Biomed Res Int. 2017;2017:2746471 https:\/\/doi.org\/10.1155\/2017\/2746471.","journal-title":"Biomed Res Int"},{"key":"2704_CR3","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/1471-0528.14236","volume":"124","author":"JA Lavery","year":"2017","unstructured":"Lavery JA, Friedman AM, Keyes KM, Wright JD, Ananth CV. Gestational diabetes in the United States: temporal changes in prevalence rates between 1979 and 2010. BJOG. 2017;124:804\u201313 https:\/\/doi.org\/10.1111\/1471-0528.14236.","journal-title":"BJOG."},{"issue":"6","key":"2704_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/jcm7060120","volume":"7","author":"Natassia Rodrigo","year":"2018","unstructured":"Rodrigo N, Glastras SJ. The emerging role of biomarkers in the diagnosis of gestational diabetes mellitus. J Clin Med. 2018;7 https:\/\/doi.org\/10.3390\/jcm7060120.","journal-title":"Journal of Clinical Medicine"},{"key":"2704_CR5","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1001\/jama.2015.16561","volume":"315","author":"DT O'Keeffe","year":"2016","unstructured":"O'Keeffe DT, Maraka S, Rizza RA. HbA1c in the evaluation of diabetes mellitus. JAMA. 2016;315:605\u20136 https:\/\/doi.org\/10.1001\/jama.2015.16561.","journal-title":"JAMA."},{"key":"2704_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2337\/dc10-1206","volume":"34","author":"S Colagiuri","year":"2011","unstructured":"Colagiuri S, Lee CM, Wong TY, Balkau B, Shaw JE, Borch-Johnsen K, et al. Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. Diabetes Care. 2011;34:145\u201350 https:\/\/doi.org\/10.2337\/dc10-1206.","journal-title":"Diabetes Care"},{"key":"2704_CR7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1590\/2359-3997000000272","volume":"61","author":"PAC Freitas","year":"2017","unstructured":"Freitas PAC, Ehlert LR, Camargo JL. Glycated albumin: a potential biomarker in diabetes. Arch Endocrinol Metab. 2017;61:296\u2013304 https:\/\/doi.org\/10.1590\/2359-3997000000272.","journal-title":"Arch Endocrinol Metab"},{"key":"2704_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1507\/endocrj.K10E-410","volume":"59","author":"H Yuji","year":"2012","unstructured":"Yuji H, Ikki S, Yasue O, Masao N. Determination of reference intervals of glycated albumin and hemoglobin A1c in healthy pregnant Japanese women and analysis of their time courses and influencing factors during pregnancy. Endocr J. 2012;59:145\u201351.","journal-title":"Endocr J"},{"key":"2704_CR9","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/0002-9378(83)90443-X","volume":"147","author":"RL Phelps","year":"1983","unstructured":"Phelps RL, Honig GR, Green D, Metzger BE, Frederiksen MC, Freinkel N. Biphasic changes in hemoglobin A1c concentrations during normal human pregnancy. Am J Obstet Gynecol. 1983;147:651\u20133 https:\/\/doi.org\/10.1016\/0002-9378(83)90443-x.","journal-title":"Am J Obstet Gynecol"},{"key":"2704_CR10","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1080\/01443615.2019.1584886","volume":"39","author":"N Mendes","year":"2019","unstructured":"Mendes N, Alves M, Andrade R, Ribeiro RT, Papoila AL, Serrano F. Association between glycated haemoglobin, glycated albumin and fructosamine with neonatal birthweight and large-for-date status infants in gestational diabetes mellitus: a prospective cohort study. J Obstet Gynaecol. 2019;39:768\u201373 https:\/\/doi.org\/10.1080\/01443615.2019.1584886.","journal-title":"J Obstet Gynaecol"},{"key":"2704_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/jdi.12383","volume":"7","author":"HP Li","year":"2016","unstructured":"Li HP, Wang FH, Tao MF, Huang YJ, Jia WP. Association between glycemic control and birthweight with glycated albumin in Chinese women with gestational diabetes mellitus. J Diabetes Investig. 2016;7:48\u201355 https:\/\/doi.org\/10.1111\/jdi.12383.","journal-title":"J Diabetes Investig"},{"key":"2704_CR12","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1080\/14767058.2017.1333103","volume":"31","author":"D Sugawara","year":"2018","unstructured":"Sugawara D, Sato H, Ichihashi K, Nagai K, Kawano A. Glycated albumin level during late pregnancy as a predictive factor for neonatal outcomes of women with diabetes. J Matern Fetal Neonatal Med. 2018;31:2007\u201312 https:\/\/doi.org\/10.1080\/14767058.2017.1333103.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2704_CR13","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1177\/0004563218763695","volume":"55","author":"I Shimizu","year":"2018","unstructured":"Shimizu I, Hiramatsu Y, Omori Y, Nakabayashi M, Group JGAS. Comparison of HbA1c and glycated albumin as a control marker for newborn complications in diabetic women in a multicentre study in Japan (Japan glycated albumin study group: study 2). Ann Clin Biochem. 2018;55:639\u201346 https:\/\/doi.org\/10.1177\/0004563218763695.","journal-title":"Ann Clin Biochem"},{"key":"2704_CR14","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1253\/circj.CJ-16-1087","volume":"80","author":"A Goda","year":"2016","unstructured":"Goda A, Masuyama T. Obesity and Overweight in Asian People. Circ J. 2016;80:2425\u20136 https:\/\/doi.org\/10.1253\/circj.CJ-16-1087.","journal-title":"Circ J"},{"key":"2704_CR15","unstructured":"Clinical and Laboratory Standard Institute. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline, 3rd edn. 2008."},{"key":"2704_CR16","doi-asserted-by":"publisher","first-page":"676","DOI":"10.2337\/dc09-1848","volume":"33","author":"BE Metzger","year":"2010","unstructured":"International Association of D, Pregnancy Study Groups Consensus P, Metzger BE, Gabbe SG, Persson B, Buchanan TA, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676\u201382 https:\/\/doi.org\/10.2337\/dc09-1848.","journal-title":"Diabetes Care"},{"issue":"5","key":"2704_CR17","doi-asserted-by":"publisher","first-page":"e22097","DOI":"10.1002\/jcla.22097","volume":"31","author":"Qiang Zhou","year":"2016","unstructured":"Zhou Q, Shi DB, Lv LY. The establishment of biological reference intervals of nontraditional glycemic markers in a Chinese population. J Clin Lab Anal. 2017;31 https:\/\/doi.org\/10.1002\/jcla.22097.","journal-title":"Journal of Clinical Laboratory Analysis"},{"key":"2704_CR18","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1177\/193229681100500619","volume":"5","author":"T Kohzuma","year":"2011","unstructured":"Kohzuma T, Yamamoto T, Uematsu Y, Shihabi ZK, Freedman BI. Basic performance of an enzymatic method for glycated albumin and reference range determination. J Diabetes Sci Technol. 2011;5:1455\u201362 https:\/\/doi.org\/10.1177\/193229681100500619.","journal-title":"J Diabetes Sci Technol"},{"key":"2704_CR19","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1373\/clinchem.2017.285742","volume":"64","author":"E Selvin","year":"2018","unstructured":"Selvin E, Warren B, He X, Sacks DB, Saenger AK. Establishment of community-based reference intervals for Fructosamine, Glycated albumin, and 1,5-Anhydroglucitol. Clin Chem. 2018;64:843\u201350 https:\/\/doi.org\/10.1373\/clinchem.2017.285742.","journal-title":"Clin Chem"},{"key":"2704_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cca.2006.10.013","volume":"378","author":"M Koga","year":"2007","unstructured":"Koga M, Otsuki M, Matsumoto S, Saito H, Mukai M, Kasayama S. Negative association of obesity and its related chronic inflammation with serum glycated albumin but not glycated hemoglobin levels. Clin Chim Acta. 2007;378:48\u201352 https:\/\/doi.org\/10.1016\/j.cca.2006.10.013.","journal-title":"Clin Chim Acta"},{"key":"2704_CR21","first-page":"1129","volume":"63","author":"N Duan","year":"2017","unstructured":"Duan N, Zhu SN, Li HX, Jiao LL, Yang HY, Guo Q. Assessment of Glycated albumin as a useful Indicator for renal dysfunction in diabetic and nondiabetic population. Clin Lab. 2017;63:1129.","journal-title":"Clin Lab"},{"key":"2704_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s40618-016-0605-7","volume":"41","author":"J Zhu","year":"2018","unstructured":"Zhu J, Chen Y, Li C, Tao M, Teng Y. The diagnostic value of glycated albumin in gestational diabetes mellitus. J Endocrinol Investig. 2018;41:121\u20138 https:\/\/doi.org\/10.1007\/s40618-016-0605-7.","journal-title":"J Endocrinol Investig"},{"issue":"Suppl 1","key":"2704_CR23","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc14-S014","volume":"37","author":"American Diabetes A","year":"2014","unstructured":"American Diabetes A. Standards of medical care in diabetes--2014. Diabetes Care. 2014;37(Suppl 1):S14\u201380 https:\/\/doi.org\/10.2337\/dc14-S014.","journal-title":"Diabetes Care"},{"key":"2704_CR24","doi-asserted-by":"publisher","unstructured":"Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. Diabetes Res Clin Pract. 2014;103:341\u201363. https:\/\/doi.org\/10.1016\/j.diabres.2013.10.012.","DOI":"10.1016\/j.diabres.2013.10.012"},{"key":"2704_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/2042018817742580","volume":"8","author":"B Saglam","year":"2017","unstructured":"Saglam B, Uysal S, Sozdinler S, Dogan OE, Onvural B. Diagnostic value of glycemic markers HbA1c, 1,5-anhydroglucitol and glycated albumin in evaluating gestational diabetes mellitus. Ther Adv Endocrinol Metab. 2017;8:161\u20137 https:\/\/doi.org\/10.1177\/2042018817742580.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2704_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.cca.2014.03.001","volume":"433","author":"M Koga","year":"2014","unstructured":"Koga M. Glycated albumin; clinical usefulness. Clin Chim Acta. 2014;433:96\u2013104 https:\/\/doi.org\/10.1016\/j.cca.2014.03.001.","journal-title":"Clin Chim Acta"},{"key":"2704_CR27","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.3892\/etm.2015.2808","volume":"10","author":"Y Huang","year":"2015","unstructured":"Huang Y, Hu Y, Ma YU, Ye G. Glycated albumin is an optimal biomarker for gestational diabetes mellitus. Exp Ther Med. 2015;10:2145\u20139 https:\/\/doi.org\/10.3892\/etm.2015.2808.","journal-title":"Exp Ther Med"},{"key":"2704_CR28","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/j.1440-1681.2010.05417.x","volume":"37","author":"XJ Ma","year":"2010","unstructured":"Ma XJ, Pan JM, Bao YQ, Zhou J, Tang JL, Li Q, et al. Combined assessment of glycated albumin and fasting plasma glucose improves the detection of diabetes in Chinese subjects. Clin Exp Pharmacol Physiol. 2010;37:974\u20139 https:\/\/doi.org\/10.1111\/j.1440-1681.2010.05417.x.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2704_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcla.22085","volume":"31","author":"AN Reynolds","year":"2017","unstructured":"Reynolds AN, Duncan A, Kruimer D, Venn BJ. Glycated albumin is associated with body mass index in euglycemic adults but is not predictive of postprandial blood glucose response. J Clin Lab Anal. 2017;31:1\u20134 https:\/\/doi.org\/10.1002\/jcla.22085.","journal-title":"J Clin Lab Anal"},{"key":"2704_CR30","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s40618-016-0607-5","volume":"40","author":"E Chiefari","year":"2017","unstructured":"Chiefari E, Arcidiacono B, Foti D, Brunetti A. Gestational diabetes mellitus: an updated overview. J Endocrinol Investig. 2017;40:899\u2013909 https:\/\/doi.org\/10.1007\/s40618-016-0607-5.","journal-title":"J Endocrinol Investig"},{"issue":"Suppl 2","key":"2704_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000371628","volume":"66","author":"K Kc","year":"2015","unstructured":"Kc K, Shakya S, Zhang H. Gestational diabetes mellitus and macrosomia: a literature review. Ann Nutr Metab. 2015;66(Suppl 2):14\u201320 https:\/\/doi.org\/10.1159\/000371628.","journal-title":"Ann Nutr Metab"},{"key":"2704_CR32","first-page":"165","volume":"32","author":"YC Zhang","year":"2017","unstructured":"Zhang YC, Ni YH, Ji X, Ying CM. Correlation of neonate birth weight with glycated hemoglobin A1c and glycated albumin levels in patients with gestational diabetes mellitus. Lab Med. 2017;32:165\u20138 [in Chinese].","journal-title":"Lab Med"},{"key":"2704_CR33","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.pedneo.2016.02.003","volume":"57","author":"D Sugawara","year":"2016","unstructured":"Sugawara D, Maruyama A, Imanishi T, Sugiyama Y, Ichihashi K. Complications in infants of diabetic mothers related to Glycated albumin and hemoglobin levels during pregnancy. Pediatr Neonatol. 2016;57:496\u2013500 https:\/\/doi.org\/10.1016\/j.pedneo.2016.02.003.","journal-title":"Pediatr Neonatol"},{"key":"2704_CR34","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/S0002-9378(03)00828-7","volume":"189","author":"PM Catalano","year":"2003","unstructured":"Catalano PM, Thomas A, Huston-Presley L, Amini SB. Increased fetal adiposity: a very sensitive marker of abnormal in utero development. Am J Obstet Gynecol. 2003;189:1698\u2013704 https:\/\/doi.org\/10.1016\/s0002-9378(03)00828-7.","journal-title":"Am J Obstet Gynecol"},{"key":"2704_CR35","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4103\/ijem.IJEM_582_17","volume":"22","author":"R Kumari","year":"2018","unstructured":"Kumari R, Dalal V, Kachhawa G, Sahoo I, Khadgawat R, Mahey R, et al. Maternal and perinatal outcome in gestational diabetes mellitus in a tertiary Care Hospital in Delhi. Indian J Endocrinol Metab. 2018;22:116\u201320 https:\/\/doi.org\/10.4103\/ijem.IJEM_582_17.","journal-title":"Indian J Endocrinol Metab"},{"key":"2704_CR36","first-page":"1650","volume":"27","author":"H Gao","year":"2012","unstructured":"Gao H. The association between glycemic control and pregnancy outcomes in 90 gestational diabetes mellitus. Matern Child Health Care China. 2012;27:1650\u20132 [in Chinese].","journal-title":"Matern Child Health Care China"},{"key":"2704_CR37","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.2337\/dc11-0268","volume":"34","author":"DK Tobias","year":"2011","unstructured":"Tobias DK, Hu FB, Forman JP, Chavarro J, Zhang C. Increased risk of hypertension after gestational diabetes mellitus: findings from a large prospective cohort study. Diabetes Care. 2011;34:1582\u20134 https:\/\/doi.org\/10.2337\/dc11-0268.","journal-title":"Diabetes Care"},{"key":"2704_CR38","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/jhh.2017.46","volume":"31","author":"L Wang","year":"2017","unstructured":"Wang L, Leng J, Liu H, Zhang S, Wang J, Li W, Li W, Li N, Zhang T, Baccarelli AA, et al. Association between hypertensive disorders of pregnancy and the risk of postpartum hypertension: a cohort study in women with gestational diabetes. J Hum Hypertens. 2017;31:725\u201330 https:\/\/doi.org\/10.1038\/jhh.2017.46.","journal-title":"J Hum Hypertens"},{"key":"2704_CR39","doi-asserted-by":"publisher","first-page":"957","DOI":"10.4103\/2230-8210.122597","volume":"17","author":"Vanlalhruaii","year":"2013","unstructured":"Vanlalhruaii, Ranabir S, Prasad L, Singh NN, Singh TP. Prevalence of gestational diabetes mellitus and its correlation with blood pressure in Manipuri women. Indian J Endocrinol Metab. 2013;17:957\u201361 https:\/\/doi.org\/10.4103\/2230-8210.122597.","journal-title":"Indian J Endocrinol Metab"},{"key":"2704_CR40","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00404-007-0359-8","volume":"276","author":"Y Yogev","year":"2007","unstructured":"Yogev Y, Langer O. Spontaneous preterm delivery and gestational diabetes: the impact of glycemic control. Arch Gynecol Obstet. 2007;276:361\u20135 https:\/\/doi.org\/10.1007\/s00404-007-0359-8.","journal-title":"Arch Gynecol Obstet"},{"key":"2704_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2017.e00369","volume":"3","author":"H Kinoshita","year":"2017","unstructured":"Kinoshita H, Watanabe K, Azma T, Feng GG, Akahori T, Hayashi H, et al. Human serum albumin and oxidative stress in preeclamptic women and the mechanism of albumin for stress reduction. Heliyon. 2017;3:e00369 https:\/\/doi.org\/10.1016\/j.heliyon.2017.e00369.","journal-title":"Heliyon."},{"key":"2704_CR42","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/bs.pmbts.2019.01.007","volume":"162","author":"X Wang","year":"2019","unstructured":"Wang X, Zhang R, Zhang L, Tian Z. Glycated serum proteins: high in pancreatic cancer and low in preeclampsia. Prog Mol Biol Transl Sci. 2019;162:321\u201333 https:\/\/doi.org\/10.1016\/bs.pmbts.2019.01.007.","journal-title":"Prog Mol Biol Transl Sci"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-019-2704-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-019-2704-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-019-2704-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T19:14:34Z","timestamp":1609528474000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-019-2704-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,3]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2704"],"URL":"https:\/\/doi.org\/10.1186\/s12884-019-2704-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.14443\/v1","asserted-by":"object"}]},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,3]]},"assertion":[{"value":"21 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Beijing Obstetrics and Gynecology Hospital, Capital Medical University (approval number: 2017-KY-070-01). The verbal consents from the participants were required as no clinical intervention was involved, which was approved by the ethical committee of our institute.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}